{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:52:34Z","timestamp":1790376754655,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Oncology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>External radiation therapy for bladder cancer requires large planning target volumes (PTVs) due to the daily anatomy of the bladder. Online adaptive radiotherapy (oART) can reduce the PTV by considering daily anatomical changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>We performed oART in 8 patients with muscle-invasive bladder cancer between June 10, 2022, and April 14, 2023, on an Ethos linear accelerator (Varian, Palo Alto, USA). Using the 496 cone-beam computed tomography (CBCT) images of the fractions, we retrospectively compared the differences in volumetric changes between oART and image-guided and intensity-modulated radiotherapy (IGRT\/IMRT). According to our local protocol, for oART, a patient-specific PTV margin was created based on the intrafractional clinical target volume (CTV) changes observed during the first three fractions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The average duration of treatment was 14.8\u202fmin (range 7\u201349\u202fmin). The average volume of the PTV with oART and IGRT\/IMRT was 296.8\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      (range 114.5\u2013810.4\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      ) and 416.5\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      (range 188.2\u2013991.3\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      ), respectively, representing a 30% reduction with oART. This new technique resulted in an average reduction of 43.9% in the volume of unnecessarily irradiated healthy tissues. Geometrical miss of the CTV occurred in 13 fractions with IGRT\/IMRT, with an average of 9.4\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      of missed volume (range 0.4\u201356.4\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      , standard deviation [SD] 15.73), for oART in 7 fractions, with an average missed volume of 4\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      (range 0.4\u201321.2\u202fcm\n                      <jats:sup>3<\/jats:sup>\n                      , SD: 7.6).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The use of patient-specific margins in oART allows for reduction of the PTV and dose to healthy tissues while achieving equal or better target coverage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-025-02397-w","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T04:59:46Z","timestamp":1744693186000},"page":"1162-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduction of the planning target volume with daily online adaptive radiotherapy in bladder cancer"],"prefix":"10.1007","volume":"201","author":[{"given":"Levente","family":"Varga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"G\u00e1ldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domonkos","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Herein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Pulugor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Nahaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Gesztesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kliton","family":"Jorgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Tak\u00e1csi Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Polg\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"\u00c1goston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"1","key":"2397_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00345-015-1729-7","volume":"34","author":"B Kiss","year":"2016","unstructured":"Kiss\u00a0B, Burkhard\u00a0FC, Thalmann\u00a0GN (2016) Open radical cystectomy: still the gold standard for muscle invasive bladder cancer. World J Urol 34(1):33\u201339 (Jan 1)","journal-title":"World J Urol"},{"issue":"5","key":"2397_CR2","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijrobp.2018.04.070","volume":"101","author":"AC Tree","year":"2018","unstructured":"Tree\u00a0AC, Jones\u00a0K, Hafeez\u00a0S, Sharabiani\u00a0MTA, Harrington\u00a0KJ, Lalondrelle\u00a0S et\u00a0al (2018) Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. Int J Radiat Oncol Biol Phys 101(5):1168\u20131171","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2397_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ijrobp.2020.12.033","volume":"110","author":"G Marcq","year":"2021","unstructured":"Marcq\u00a0G, Souhami\u00a0L, Cury\u00a0FL, Salimi\u00a0A, Aprikian\u00a0A, Tanguay\u00a0S et\u00a0al (2021) Phase\u00a01 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys 110(3):738\u2013741","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2397_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2003.10.039","volume":"59","author":"L Fokdal","year":"2004","unstructured":"Fokdal\u00a0L, Honor\u00e9\u00a0H, H\u00f8yer\u00a0M, Meldgaard\u00a0P, Fode\u00a0K, Von Der Maase\u00a0H (2004) Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 59(2):436\u2013444 (Jun 1)","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2397_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.radonc.2014.08.019","volume":"113","author":"HM Dees-Ribbers","year":"2014","unstructured":"Dees-Ribbers\u00a0HM, Betgen\u00a0A, Pos\u00a0FJ, Witteveen\u00a0T, Remeijer\u00a0P, Van Herk\u00a0M (2014) Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A\u00a0comparison of full and empty bladders. Radiother Oncol 113(2):254\u2013259 (Nov 1)","journal-title":"Radiother Oncol"},{"issue":"2","key":"2397_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1754-9485.2009.02066.x","volume":"53","author":"F Foroudi","year":"2009","unstructured":"Foroudi\u00a0F, Wong\u00a0J, Haworth\u00a0A, Baille\u00a0A, McAlpine\u00a0J, Rolfo\u00a0A, Kron\u00a0T, Roxby\u00a0P, Paneghel\u00a0A, Williams\u00a0S, Duchesne\u00a0G, Tai\u00a0K (2009) Offline adaptive radiotherapy for bladder cancer using cone beam computed tomography. J\u00a0Med Imag Rad Onc 53(2):226\u2013233","journal-title":"J Med Imag Rad Onc"},{"key":"2397_CR7","doi-asserted-by":"publisher","first-page":"637591","DOI":"10.3389\/fonc.2021.637591","volume":"11","author":"A Hijab","year":"2021","unstructured":"Hijab\u00a0A, Tocco\u00a0B, Hanson\u00a0I, Meijer\u00a0H, Nyborg\u00a0CJ, Bertelsen\u00a0AS, Smeenk\u00a0RJ, Smith\u00a0G, Michalski\u00a0J, Baumann\u00a0BC, Hafeez\u00a0S (2021) MR-Guided Adaptive Radiotherapy for Bladder Cancer. Front Oncol 11:637591","journal-title":"Front Oncol"},{"issue":"4","key":"2397_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jmrs.129","volume":"62","author":"AZ Kibrom","year":"2015","unstructured":"Kibrom\u00a0AZ, Knight\u00a0KA (2015) Adaptive radiation therapy for bladder cancer: a\u00a0review of adaptive techniques used in clinical practice. J\u00a0of Medical Radiation Sci 62(4):277","journal-title":"J of Medical Radiation Sci"},{"issue":"6","key":"2397_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clon.2021.03.023","volume":"33","author":"V Kong","year":"2021","unstructured":"Kong\u00a0V, Hansen\u00a0VN, Hafeez\u00a0S (2021) Image-guided Adaptive Radiotherapy for Bladder Cancer. Clin Oncol 33(6):350\u2013368 (Jun 1)","journal-title":"Clin Oncol"},{"issue":"2","key":"2397_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","volume":"22","author":"A Choudhury","year":"2021","unstructured":"Choudhury\u00a0A, Porta\u00a0N, Hall\u00a0E, Song\u00a0YP, Owen\u00a0R, MacKay\u00a0R et\u00a0al (2021) Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials. Lancet Oncol 22(2):246\u2013255 (Feb 1;)","journal-title":"Lancet Oncol"},{"issue":"1","key":"2397_CR11","doi-asserted-by":"publisher","first-page":"102662","DOI":"10.1016\/j.ejmp.2023.102662","volume":"113","author":"S Wegener","year":"2023","unstructured":"Wegener\u00a0S, Schindhelm\u00a0R, Tamihardja\u00a0J, Sauer\u00a0OA, Razinskas\u00a0G (2023) Evaluation of the Ethos synthetic computed tomography for bolus-covered surfaces. Phys Medica 113(1):102662 (Sep)","journal-title":"Phys Medica"},{"issue":"12","key":"2397_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/acm2.13056","volume":"21","author":"Y Hu","year":"2020","unstructured":"Hu\u00a0Y, Byrne\u00a0M, Archibald-Heeren\u00a0B, Collett\u00a0N, Liu\u00a0G, Aland\u00a0T (2020) Validation of the preconfigured Varian Ethos Acuros XB Beam Model for treatment planning dose calculations: A\u00a0dosimetric study. J\u00a0Appl Clin Med Phys 21(12):27\u201342 (Dec 1)","journal-title":"J Appl Clin Med Phys"},{"issue":"11","key":"2397_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11934-015-0547-1","volume":"16","author":"MA Feuerstein","year":"2015","unstructured":"Feuerstein\u00a0MA, Goenka\u00a0A (2015) Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy. Curr Urol Rep 16(11):1\u20136 (Nov 10)","journal-title":"Curr Urol Rep"},{"key":"2397_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3109\/0284186X.2014.928418","volume":"53","author":"J Sondergaard","year":"2014","unstructured":"Sondergaard\u00a0J, Holmberg\u00a0M, Jakobsen\u00a0AR, Agerb\u00e6k\u00a0M, Muren\u00a0LP, Hoyer\u00a0M (2014) A\u00a0comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer. Acta Oncol 53:1321\u20131328","journal-title":"Acta Oncol"},{"issue":"3","key":"2397_CR15","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","volume":"76","author":"BD Kavanagh","year":"2010","unstructured":"Kavanagh\u00a0BD, Pan\u00a0CC, Dawson\u00a0LA, Das\u00a0SK, Li\u00a0XA, Ten Haken\u00a0RK et\u00a0al (2010) Radiation Dose-Volume Effects in the Stomach and Small Bowel. Int J Radiat Oncol 76(3):S101\u20137 (Mar 1)","journal-title":"Int J Radiat Oncol"},{"key":"2397_CR16","doi-asserted-by":"crossref","unstructured":"Mcdonald F, Waters R, Gulliford S, Hall E, James N, Huddart RA (2015) Defining bowel dose volume constraints for bladder radiotherapy treatment planning. Clin Oncol: 22\u201329 (Jan)","DOI":"10.1016\/j.clon.2014.09.016"},{"issue":"1","key":"2397_CR17","first-page":"1","volume":"14","author":"R Jadon","year":"2024","unstructured":"Jadon\u00a0R, Higgins\u00a0E, Hanna\u00a0L, Evans\u00a0M, Coles\u00a0B, Staffurth\u00a0J (2024) A\u00a0systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy. Radiat Oncol 14(1):1\u201314 (2019 Apr 3)","journal-title":"Radiat Oncol"},{"issue":"2","key":"2397_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijrobp.2013.06.2044","volume":"87","author":"RA Huddart","year":"2013","unstructured":"Huddart\u00a0RA, Hall\u00a0E, Hussain\u00a0SA, Jenkins\u00a0P, Rawlings\u00a0C, Tremlett\u00a0J et\u00a0al (2013) Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: Results of the BC2001 Trial (CRUK\/01\/004). Int J Radiat Oncol Biol Phys 87(2):261\u2013269 (Oct)","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2397_CR19","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/j.clon.2021.03.013","volume":"33","author":"V Fonteyne","year":"2021","unstructured":"Fonteyne\u00a0V, Sargos\u00a0P (2021) What is the Optimal Dose, Fractionation and Volume for Bladder Radiotherapy? Clin Oncol 33(6):e245\u201350 (Jun 1)","journal-title":"Clin Oncol"},{"issue":"2","key":"2397_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.meddos.2018.03.004","volume":"44","author":"VC Kong","year":"2019","unstructured":"Kong\u00a0VC, Taylor\u00a0A, Chung\u00a0P, Craig\u00a0T, Rosewall\u00a0T (2019) Comparison of 3 image-guided adaptive strategies for bladder locoregional radiotherapy. Med Dosim 44(2):111\u2013116 (Jun 1)","journal-title":"Med Dosim"},{"issue":"3","key":"2397_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.radonc.2013.08.045","volume":"109","author":"A Vestergaard","year":"2013","unstructured":"Vestergaard\u00a0A, Muren\u00a0LP, S\u00f8ndergaard\u00a0J, Elstr\u00f8m\u00a0UV, H\u00f8yer\u00a0M, Petersen\u00a0JB (2013) Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: a\u00a0dose accumulation comparison. Radiother Oncol 109(3):457\u2013462 (Dec)","journal-title":"Radiother Oncol"},{"issue":"3","key":"2397_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijrobp.2020.07.2231","volume":"108","author":"P Sibolt","year":"2020","unstructured":"Sibolt\u00a0P, Andersson\u00a0L, Calmels\u00a0L, Sjostrom\u00a0D, Behrens\u00a0CF, Lindberg\u00a0H et\u00a0al (2020) Results of a\u00a0Pilot Study on Online Adaptive Radiotherapy of Bladder Cancer with Artificial Intelligence-driven Full Re-optimization on the Anatomy of the Day. Int J Radiat Oncol 108(3):79\u201380 (Nov 1)","journal-title":"Int J Radiat Oncol"},{"key":"2397_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.radonc.2022.03.014","volume":"171","author":"LM \u00c5str\u00f6m","year":"2022","unstructured":"\u00c5str\u00f6m\u00a0LM, Behrens\u00a0CP, Calmels\u00a0L, Sj\u00f6str\u00f6m\u00a0D, Geertsen\u00a0P, Mouritsen\u00a0LS et\u00a0al (2022) Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits: oART of bladder cancer: initial experience and dosimetric benefits. Radiother Oncol 171:37\u201342 (Jun 1)","journal-title":"Radiother Oncol"},{"key":"2397_CR24","doi-asserted-by":"crossref","unstructured":"Azzarouali S, Goudschaal K, Visser J, Hulshof M, Admiraal M, van Wieringen N et\u00a0al (2023) Online adaptive radiotherapy for bladder cancer using a\u00a0simultaneous integrated boost and fiducial markers. Radiat Oncol 18(1) (Dec 1)","DOI":"10.1186\/s13014-023-02348-8"},{"issue":"9","key":"2397_CR25","doi-asserted-by":"publisher","first-page":"e68863","DOI":"10.7759\/cureus.68863","volume":"16","author":"S Azzarouali","year":"2024","unstructured":"Azzarouali\u00a0S, Goudschaal\u00a0K, Visser\u00a0J, Bel\u00a0A, Dani\u00ebls\u00a0L, den Boer\u00a0D (2024) Cone-Beam Computed Tomography-Guided Online Adaptive Radiotherapy: Promising Results for Bladder Cancer Case. Cureus 16(9):e68863. https:\/\/doi.org\/10.7759\/cureus.68863 (Sep 7)","journal-title":"Cureus"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02397-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:41:01Z","timestamp":1761154861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02397-w","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.\u00a0Varga, \u00c1.\u00a0G\u00e1ldi,D.\u00a0Szegedi, A.\u00a0Herein, D.\u00a0Pulugor, I.\u00a0Nahaji, L.\u00a0Gesztesi, K.\u00a0Jorgo, Z.\u00a0Tak\u00e1csi Nagy, C.\u00a0Polg\u00e1r, Z.\u00a0Kocsis, T.\u00a0Major, and P.\u00a0\u00c1goston declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}